Qilu Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BORTEZOMIB (NON-STERILE, API), with a corresponding US DMF Number 29308.
Remarkably, this DMF maintains an Active status since its submission on May 06, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 06, 2016, and payment made on May 21, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II